Yıl: 2020 Cilt: 26 Sayı: 1 Sayfa Aralığı: 9 - 14 Metin Dili: İngilizce DOI: 10.14744/tjtes.2019.49768 İndeks Tarihi: 10-11-2020

The effects of dexmedetomidine in increased intestinal permeability after traumatic brain injury: An experimental study

Öz:
BACKGROUND: This study aims to investigate whether or not dexmedetomidine (DEX) application affects inflammation, increasedintestinal mucosa damage and intestinal permeability in traumatic brain injury (TBI).METHODS: The rats included in our study were randomized into three groups as the control group (Group 1, n=10), trauma group(Group 2, n=10) and the trauma+dexmedetomidine group (Group 3, n=10). While trauma was not induced in the control group, headtrauma was induced in all rats in Groups 2 and 3 with the same method. The rats in Group 3 additionally received the DEX application. Intestinal THF-a, serum TNF-a, IL-6, IL-1b and D-lactate levels were measured six hours post-trauma to assess systemic andlocal infection. Histopathological evaluation of the terminal ileum was performed at the 6th hour to assess mucosal damage. Intestinalpermeability was evaluated by measuring the level of dextran injected into the 5-cm ileum segment adhered to the proximal and distaledges at the 30th minute in the blood taken by cardiac puncture.RESULTS: Intestinal TNF-a (p=0.003), serum TNF-a (p=0.009), IL-6 (p=0.002), IL-1b (p=0.001), and D-lactate levels measured inGroup 3 (p=0.046) were significantly lower than those measured in Group 2. Dextran level measured in blood in Group 3 was observed significantly lower than that of Group 2 (p<0.001). Histopathological evaluation of the intestines revealed no injuries in theileum of the rats in Group 1, injury in the ileum, villus atrophy and mucosal damage in the rats in Group 2, and a significant recoverywas observed in Group 3 in comparison to Group 2.CONCLUSION: It was seen in our study that DEX reduced TBI-induced increased inflammation, intestinal mucosa damage andintestinal permeability. These results suggest that DEX may ameliorate the damage done to the intestinal tissue by modulating postTBI inflammatory responses.
Anahtar Kelime:

Travmatik beyin hasarında artmış bağırsak geçirgenliğine deksmedetomidinin etkisi: Deneysel çalışma

Öz:
AMAÇ: Deksmedetomidin (DEX) uygulamasının travmatik beyin hasarında (TBH) enflamasyonu, artan bağırsak mukoza hasarını ve bağırsak geçirgenliğini etkileme durumu araştırıldı. GEREÇ VE YÖNTEM: Çalışmamızda değerlendirdiğimiz hayvanlar kontrol grubu (Grup 1, n=10), travma grubu (Grup 2, n=10) ve travma + deksmetetomdin grubu (Grup 3, n=10) olmak üzere üç gruba randomize edildi. Kontrol grubuna travma uygulanmazken, Grup 2 ve 3’deki sıçanların hepsine aynı yöntemle kafa travması uygulandı. Grup 3’deki sıçanlara ek olarak intraperitoneal DEX uygulaması yapıldı. Sistemik ve lokal enflamasyonu değerlendirmek için travmadan 6 saat sonra bağırsak TNF-a, serum TNF-a, IL-6, IL-1b, D-laktat düzeyleri ölçüldü. Mukoza hasarını değerlendirmek için 6. saatte terminal ileumun histopatolojik incelemesi yapıldı. İntestinal geçirgenliği değerlendirmek için ise proksimal ve distal uçlarından bağlanan 5 cm’lik ileum segmentine enjekte edilen dekstranın 30. dakikada kardiyak ponksiyonla alınan kandaki düzeyi ölçüldü. BULGULAR: Grup 3’te ölçülen bağırsak TNF-a (p=0.003), serum TNF-a (p=0.009), IL-6 (p=0.002), IL-1b (p=0.001), D-laktat düzeyleri (p=0.046), Grup 2’ye göre anlamlı ölçüde düşük saptandı. Grup 3’te kanda ölçülen dekstran düzeyi Grup 2’ye göre anlamlı düzeyde düşük gözlendi (p<0.001). Bağırsakların histopatolojik incelemesinde ise; Grup 1’deki sıçanların ileumunda hasar yok, Grup 2’deki sıçanların ileumunda; villus atrofisi ve mukozal hasar, Grup 3’dekilerin ise Grup 2’ye göre anlamlı derecede iyileşme olduğu gözlendi. TARTIŞMA: Çalışmamızda DEX’in TBI kaynaklı artan enflamasyonu, bağırsak mukoza hasarını ve bağırsak geçirgenliğini azalttığı görüldü. Bu sonuçlar, DEX’in, TBH sonrası enflamatuvar yanıtları modüle ederek bağırsak dokusuna verilen hasarı iyileştirebileceğini göstermiştir.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Dilmen ÖK, Akçıl EF, Tunalı Y. Intensive Care Treatment in Traumatic Brain Injury. Turk J Anaesthesiol Reanim 2015;43:1−6.
  • 2. Baguley IJ, Heriseanu RE, Cameron ID, Nott MT, Slewa-Younan S. A critical review of the pathophysiology of dysautonomia following traumatic brain injury. Neurocrit Care 2008;8:293–300.
  • 3. Cook AM, Peppard A, Magnuson B. Nutrition considerations in traumatic brain injury. Nutr Clin Pract 2008;23:608−20.
  • 4. Kemp CD, Johnson JC, Riordan WP, Cotton BA. How we die: the impact of nonneurologic organ dysfunction after severe traumatic brain injury. Am Surg 2008;74:866−72.
  • 5. Bansal V, Costantini T, Kroll L, Peterson C, Loomis W, Eliceiri B, et al. Traumatic brain injury and intestinal dysfunction: uncovering the neuroenteric axis. J Neurotrauma 2009;26:1353−9.
  • 6. Feighery L, Smyth A, Keely S, Baird AW, O’Connor WT, Callanan JJ, et al. Increased intestinal permeability in rats subjected to traumatic frontal lobe percussion brain injury. J Trauma 2008;64:131−7.
  • 7. Brandão PG, Lobo FR, Ramin SL, Sakr Y, Machado MN, Lobo SM. Dexmedetomidine as an Anesthetic Adjuvant in Cardiac Surgery: a Cohort Study. Braz J Cardiovasc Surg 2016;31:213−8.
  • 8. Venn RM, Bradshaw CJ, Spencer R, Brealey D, Caudwell E, Naughton C, et al. Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia 1999;54:1136−42.
  • 9. Chen Y, Miao L, Yao Y, Wu W, Wu X, Gong C, et al. Dexmedetomidine Ameliorate CLP-Induced Rat Intestinal Injury via Inhibition of Inflammation. Mediators Inflamm 2015;2015:918361.
  • 10. Taniguchi T, Kidani Y, Kanakura H, Takemoto Y, Yamamoto K. Effects of dexmedetomidine on mortality rate and inflammatory responses to endotoxin-induced shock in rats. Crit Care Med 2004;32:1322−6.
  • 11. Li B, Li Y, Tian S, Wang H, Wu H, Zhang A, et al. Anti-inflammatory Effects of Perioperative Dexmedetomidine Administered as an Adjunct to General Anesthesia: A Meta-analysis. Sci Rep 2015;5:12342.
  • 12. Memiş D, Hekimoğlu S, Vatan I, Yandim T, Yüksel M, Süt N. Effects of midazolam and dexmedetomidine on inflammatory responses and gastric intramucosal pH to sepsis, in critically ill patients. Br J Anaesth 2007;98:550−2.
  • 13. Lorenz I, Vogt S. Investigations on the association of D- lactate blood concentrations with the outcome of therapy of acidosis, and with posture and demeanour in young calves with diarrhea. J Vet Med A 2006;53:490−4.
  • 14. Hang CH, Shi JX, Li JS, Li WQ, Wu W. Expressions of intestinal NFkappaB, TNF-alpha, and IL-6 following traumatic brain injury in rats. J Surg Res 2005;123:188−93.
  • 15. Lenz A, Franklin GA, Cheadle WG. Systemic inflammation after trauma. Injury 2007;38:1336−45.
  • 16. Tamion F, Richard V, Lacoume Y, Thuillez C. Intestinal preconditioning prevents systemic inflammatory response in hemorrhagic shock. Role of HO-1. Am J Physiol Gastrointest Liver Physiol 2002;283:G408−14.
  • 17. Doğan G, İpek H, Baş Y, Doğan G, Kayır S. Experimental study on prophylactic effects of vardenafil in ischemia-reperfusion model with intestinal volvulus injury in rats. J Pediatr Surg 2019;54:2172−7.
  • 18. Özkan N, Ersoy ÖF, Özsoy Z, Çakır E. Melatonin exhibits supportive effects on oxidants and anastomotic healing during intestinal ischemia/ reperfusion injury. Ulus Travma Acil Cerrahi Derg 2018;24:1−8.
  • 19. Hang CH, Shi JX, Li JS, Wu W, Yin HX. Alterations of intestinal mucosa structure and barrier function following traumatic brain injury in rats. World J Gastroenterol 2003;9:2776−81.
  • 20. Lin CY, Tsai PS, Hung YC, Huang CJ. L-type calcium channels are involved in mediating the anti-inflammatory effects of magnesium sulphate. Br J Anaesth 2010;104:44−51.
  • 21. Eser O, Fidan H, Sahin O, Cosar M, Yaman M, Mollaoglu H, et al. The influence of dexmedetomidine on ischemic rat hippocampus. Brain Res 2008;1218:250−6.
  • 22. Taniguchi T, Kurita A, Kobayashi K, Yamamoto K, Inaba H. Dose- and time-related effects of dexmedetomidine on mortality and inflammatory responses to endotoxin-induced shock in rats. J Anesth 2008;22:221−8.
  • 23. Erdogan Kayhan G, Gul M, Kayhan B, Gedik E, Ozgul U, Kurtoglu EL, et al. Dexmedetomidine ameliorates TNBS-induced colitis by inducing immunomodulator effect. J Surg Res 2013;183:733−41.
  • 24. Sun Y, Gao Q, Wu N, LI SD, Yao JX, Fan WJ. Protective effects of dexmedetomidine on intestinal ischemia reperfusion injury. Exp Ther Med 2015;10:647−52.
APA Karaca O, DOĞAN G (2020). The effects of dexmedetomidine in increased intestinal permeability after traumatic brain injury: An experimental study. , 9 - 14. 10.14744/tjtes.2019.49768
Chicago Karaca Onur,DOĞAN Güvenç The effects of dexmedetomidine in increased intestinal permeability after traumatic brain injury: An experimental study. (2020): 9 - 14. 10.14744/tjtes.2019.49768
MLA Karaca Onur,DOĞAN Güvenç The effects of dexmedetomidine in increased intestinal permeability after traumatic brain injury: An experimental study. , 2020, ss.9 - 14. 10.14744/tjtes.2019.49768
AMA Karaca O,DOĞAN G The effects of dexmedetomidine in increased intestinal permeability after traumatic brain injury: An experimental study. . 2020; 9 - 14. 10.14744/tjtes.2019.49768
Vancouver Karaca O,DOĞAN G The effects of dexmedetomidine in increased intestinal permeability after traumatic brain injury: An experimental study. . 2020; 9 - 14. 10.14744/tjtes.2019.49768
IEEE Karaca O,DOĞAN G "The effects of dexmedetomidine in increased intestinal permeability after traumatic brain injury: An experimental study." , ss.9 - 14, 2020. 10.14744/tjtes.2019.49768
ISNAD Karaca, Onur - DOĞAN, Güvenç. "The effects of dexmedetomidine in increased intestinal permeability after traumatic brain injury: An experimental study". (2020), 9-14. https://doi.org/10.14744/tjtes.2019.49768
APA Karaca O, DOĞAN G (2020). The effects of dexmedetomidine in increased intestinal permeability after traumatic brain injury: An experimental study. Ulusal Travma ve Acil Cerrahi Dergisi, 26(1), 9 - 14. 10.14744/tjtes.2019.49768
Chicago Karaca Onur,DOĞAN Güvenç The effects of dexmedetomidine in increased intestinal permeability after traumatic brain injury: An experimental study. Ulusal Travma ve Acil Cerrahi Dergisi 26, no.1 (2020): 9 - 14. 10.14744/tjtes.2019.49768
MLA Karaca Onur,DOĞAN Güvenç The effects of dexmedetomidine in increased intestinal permeability after traumatic brain injury: An experimental study. Ulusal Travma ve Acil Cerrahi Dergisi, vol.26, no.1, 2020, ss.9 - 14. 10.14744/tjtes.2019.49768
AMA Karaca O,DOĞAN G The effects of dexmedetomidine in increased intestinal permeability after traumatic brain injury: An experimental study. Ulusal Travma ve Acil Cerrahi Dergisi. 2020; 26(1): 9 - 14. 10.14744/tjtes.2019.49768
Vancouver Karaca O,DOĞAN G The effects of dexmedetomidine in increased intestinal permeability after traumatic brain injury: An experimental study. Ulusal Travma ve Acil Cerrahi Dergisi. 2020; 26(1): 9 - 14. 10.14744/tjtes.2019.49768
IEEE Karaca O,DOĞAN G "The effects of dexmedetomidine in increased intestinal permeability after traumatic brain injury: An experimental study." Ulusal Travma ve Acil Cerrahi Dergisi, 26, ss.9 - 14, 2020. 10.14744/tjtes.2019.49768
ISNAD Karaca, Onur - DOĞAN, Güvenç. "The effects of dexmedetomidine in increased intestinal permeability after traumatic brain injury: An experimental study". Ulusal Travma ve Acil Cerrahi Dergisi 26/1 (2020), 9-14. https://doi.org/10.14744/tjtes.2019.49768